Who invested in Abogen Biosciences?
Abogen Biosciences's investors include Qiming Venture Partners, Coatue, Temasek Holdings, Hill House Capital and Gaorong Capital.
Who invested in Abogen Biosciences
Funding summaryUpdated 26 Oct 2026
$300Mraised across 1 round since 2021, from 1 source
- Latest round
- Series C, $300MNov 2021
- Investors
- 5
The rounds
- Nov 2021Series C$300M
Source recorded
Founders and team
From Abogen Biosciences's own website: 1 founder, 7 on the team.
Bo YingFounder, Chairman and CEO
- Xiaotao WangVice President of Platform Biology
- Xinpeng MaSenior Vice President of Chemistry
- Zhiyi ZhangVice President of Formulation R&D
- Iain McFadyenChief AI Officer
- Peng GaoChief Technology Officer
- Wenjie SongChief Medical Officer
- Ziyi SongChief Financial Officer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Abogen Biosciences
How much has Abogen Biosciences raised?
Abogen Biosciences has raised $300M across 1 round since 2021.
When did Abogen Biosciences last raise?
Abogen Biosciences's most recent round was a Series C of $300M in Nov 2021.
What was Abogen Biosciences's biggest round?
Its most recent round, $300M in Nov 2021, is also its largest on record.
Who backed Abogen Biosciences first?
Abogen Biosciences's first round on record, in Nov 2021, was backed by Qiming Venture Partners, Coatue and Temasek Holdings and 2 others.
What stage is Abogen Biosciences at?
Abogen Biosciences's latest named round is a Series C, in Nov 2021.
Companies like Abogen Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.